Skip to main content
SpringerLink
Log in

An Immune- and Hormone-Dependent Phase During the Latency Period of SV40 Oncogenesis in Syrian Hamsters

  • Chapter
Hamster Immune Responses in Infectious and Oncologic Diseases

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 134))

  • 56 Accesses

Abstract

SV40 oncogenesis in hamsters requires a latency period ranging from three to more than 12 months. Hamsters neonatally inoculated with SV40 do not develop tumors until much later, as adults, but then the incidence of tumor-bearing hamsters is very high (1). During this latency period, the hamsters appear to be immunologically neutral to SV40 or SV40-TSTA; they are neither tolerant nor resistant, and tumor induction can be prevented by specific immunization with the virus or the tumor cells up until a few weeks before the tumor becomes palpable (2,3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ohtaki, S. Cancer Res 38 (1978) 4698.

    PubMed  CAS  Google Scholar 

  2. Deichman, G.I.; Kluchareva, T.E. Virology 24 (1964) 131.

    Article  PubMed  CAS  Google Scholar 

  3. Deichman, G.I. Adv Cancer Res 12 (1969) 101.

    Article  PubMed  CAS  Google Scholar 

  4. Lausch, R.N. et al. J Immunol 115 (1975) 682.

    PubMed  CAS  Google Scholar 

  5. Prather, S.O.; Lausch, R.N. Int J Cancer 17 (1976) 380.

    Article  PubMed  CAS  Google Scholar 

  6. Prather, S.O.; Lausch, R.N. J Immunol 118 (1977) 203.

    PubMed  CAS  Google Scholar 

  7. Glaser, M. J Exp Med 149 (1979) 774.

    Article  PubMed  CAS  Google Scholar 

  8. Gooding, L.R. J Immunol 122 (1979) 2328.

    PubMed  CAS  Google Scholar 

  9. Heimer, R.; de Vaux St. Cyr, C. Cancer Res 39 (1979) 2919.

    PubMed  CAS  Google Scholar 

  10. Volpe, E.A. Neoplasma 23 (1976) 345.

    PubMed  CAS  Google Scholar 

  11. Volpe, E.A. Experimentia 34 (1978) 113.

    Article  CAS  Google Scholar 

  12. Allison, A.C. et al. Nature 215 (1967) 185.

    Article  PubMed  CAS  Google Scholar 

  13. Allison, A.C.; Law, L.W. Proc Soc Exp Biol Med 127 (1968) 207.

    PubMed  CAS  Google Scholar 

  14. Allison, A.C.; Taylor, R.B. Cancer Res 27 (1967) 703.

    PubMed  CAS  Google Scholar 

  15. Larson, V.M. et al. Proc Soc Exp Biol Med 136 (1971) 1304.

    PubMed  CAS  Google Scholar 

  16. Law, L.W. Cancer Res 26 (1966) 551.

    PubMed  CAS  Google Scholar 

  17. Law, L.W. Fed Proc 29 (1970) 171.

    PubMed  CAS  Google Scholar 

  18. Miller, J.F.A.P. et al. Proc Soc Exp Biol Med 116 (1964) 323.

    PubMed  CAS  Google Scholar 

  19. Yohn, D.S. et al. J Natl Cancer Inst 35 (1965) 617.

    PubMed  CAS  Google Scholar 

  20. Yohn, D.S. et al. J Immunol 100 (1967) 771.

    Google Scholar 

  21. Ohtaki, S. Lab Anim Sci 29 (1979) 765.

    PubMed  CAS  Google Scholar 

  22. Ting, R.C. Nature 211 (1966) 1000.

    Article  PubMed  CAS  Google Scholar 

  23. Girardi, A.J.; Roosa, R.A. J Immunol 99 (1967) 1217.

    PubMed  CAS  Google Scholar 

  24. Tevethia, S.S. et al. J Immunol 101 (1968) 1105.

    Google Scholar 

  25. Wright, P.W. et al. J Natl Cancer Inst 51 (1973) 951.

    PubMed  CAS  Google Scholar 

  26. Tevethia, S.S. et al. J Immunol 113 (1974) 1417.

    PubMed  CAS  Google Scholar 

  27. Blasecki, J.W.; Tevethia, S.S. J Immunol 114 (1975) 244.

    PubMed  CAS  Google Scholar 

  28. Gooding, L.R. J Immunol 118 (1977) 920.

    PubMed  CAS  Google Scholar 

  29. Trinchieri, G. et al. Nature 261 (1976) 312.

    Article  PubMed  CAS  Google Scholar 

  30. Knowles, B.B. et al. J Immunol 122 (1979) 1798.

    PubMed  CAS  Google Scholar 

  31. Coggin, J.H. Cancer Res 39 (1979) 2952.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, National Institute of Health, Japan, Gakuen 4-7-1, Musashi-Murayama, Tokyo, 190-12, Japan

    Sachi Ohtaki

Authors
  1. Sachi Ohtaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The University of Texas Southwestern Medical School at Dallas, Dallas, Texas, USA

    J. Wayne Streilein , David A. Hart , Joan Stein-Streilein , William R. Duncan  & Rupert E. Billingham , , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Plenum Press, New York

About this chapter

Cite this chapter

Ohtaki, S. (1981). An Immune- and Hormone-Dependent Phase During the Latency Period of SV40 Oncogenesis in Syrian Hamsters. In: Wayne Streilein, J., Hart, D.A., Stein-Streilein, J., Duncan, W.R., Billingham, R.E. (eds) Hamster Immune Responses in Infectious and Oncologic Diseases. Advances in Experimental Medicine and Biology, vol 134. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0495-2_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0495-2_37

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0497-6

  • Online ISBN: 978-1-4757-0495-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation